Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berten Ceulemans

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
Epilepsy & Behavior : E&B|August 5, 2021
Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growthAntonio Gil-Nagel, Joseph Sullivan, Berten Ceulemans, et al.
Annals of Neurology|October 3, 2009
Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1Arvid Suls, Saul A Mullen, Yvonne G Weber, et al.
Epilepsia|February 18, 2025
Amitriptyline use in individuals with KCNQ2/3 gain-of-function variants: A retrospective cohort studyMatthias De Wachter, Charissa Millevert, Joost Nicolai, et al.
Brain : a Journal of Neurology|June 5, 2026
Kv7.2 loss-of-function causes early hyperexcitability and network remodellingNina Dirkx, Marcus Kaji, Els De Vriendt, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|October 5, 2019
Gait abnormalities in people with Dravet syndrome: A cross-sectional multi-center studyRoberto Di Marco, Ann Hallemans, Giulia Bellon, et al.
Epilepsia|August 6, 2023
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trialJoseph Sullivan, Lieven Lagae, J Helen Cross, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
JAMA Neurology|May 2, 2022
Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical TrialKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Epilepsia|October 5, 2022
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension studyKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Human Mutation|July 26, 2006
Microdeletions involving the SCN1A gene may be common in SCN1A-mutation-negative SMEI patientsArvid Suls, Kristl G Claeys, Dirk Goossens, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Epilepsy & Behavior : E&B|August 5, 2021
Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growthAntonio Gil-Nagel, Joseph Sullivan, Berten Ceulemans, et al.
Annals of Neurology|October 3, 2009
Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1Arvid Suls, Saul A Mullen, Yvonne G Weber, et al.
Epilepsia|February 18, 2025
Amitriptyline use in individuals with KCNQ2/3 gain-of-function variants: A retrospective cohort studyMatthias De Wachter, Charissa Millevert, Joost Nicolai, et al.
Brain : a Journal of Neurology|June 5, 2026
Kv7.2 loss-of-function causes early hyperexcitability and network remodellingNina Dirkx, Marcus Kaji, Els De Vriendt, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|October 5, 2019
Gait abnormalities in people with Dravet syndrome: A cross-sectional multi-center studyRoberto Di Marco, Ann Hallemans, Giulia Bellon, et al.
Epilepsia|August 6, 2023
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trialJoseph Sullivan, Lieven Lagae, J Helen Cross, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
JAMA Neurology|May 2, 2022
Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical TrialKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Epilepsia|October 5, 2022
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension studyKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Human Mutation|July 26, 2006
Microdeletions involving the SCN1A gene may be common in SCN1A-mutation-negative SMEI patientsArvid Suls, Kristl G Claeys, Dirk Goossens, et al.
Pageof 14